Shareholders' Equity (Details)				1 Months Ended			6 Months Ended	9 Months Ended
	Aug. 03, 2017 USD ($) $ / shares	Sep. 04, 2015 Employees Director shares	Jun. 01, 2015 shares	Apr. 24, 2017 shares	May 31, 2016 shares	Apr. 30, 2016 shares	Jun. 30, 2017 USD ($)	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016 USD ($) shares
Shareholders' Equity (Textual)
Stock based compensation								$ 4,829,598	$ 4,866,324
Gross proceeds from equity	$ 7,000,000
Stock award agreements [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued | shares		450,000
Stock based compensation									604,440
Recognized total expense									60,495
Number of management employees | Employees		4
Number of director | Director		1
Chairman of the Board [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued | shares			50,000
Recognized total expense								112,500	202,500
Vesting period term			24 months
Dr. Philip Frost and Steven Rubin [Member]
Shareholders' Equity (Textual)
Common stock issued, shares | shares					150,000
Recognized total expense								$ 29,500	211,890
Vesting period term					12 months
2015 Equity Plan [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued | shares								5,210,000
Shares vest upon consummation of equity and/or debt financing									5,000,000
Stock based compensation							$ 970,067	$ 1,488,596	28,808
2015 Equity Plan [Member] | Stock award agreements [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued | shares						1,150,000
Stock based compensation									$ 3,346,615
Common stock issued, shares | shares									100,000
SAB Amendments [Member]
Shareholders' Equity (Textual)
Recognized total expense								$ 104,167
Restricted common stock, description	The SAB Amendments extend the term of the agreements from May 1, 2017 until April 30, 2018 and provide for the following equity based compensation: (a) for Dr. Frost, a warrant to purchase 2,000,000 shares of the Company's Common Stock (the "Frost Warrant") and an award of 150,000 shares of the Company's unregistered restricted Common Stock and (b) for Mr. Rubin, an award of 100,000 shares of the Company's unregistered restricted Common Stock. The restricted stock vests upon the occurrence of a change of control (as defined in the SAB Amendments).
Warrant Term	5 years
Warrant exercise price | $ / shares	$ 1.00
Series A Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred stock converted shares | shares				100,100
Aggregate shares of restricted common stock | shares				250,250